CD20xCD3 Bispecific Antibodies As Standard of Care (SOC) for Relapse/Refractory (R/R) Large B-Cell Lymphoma (LBCL) - a Multicenter Retrospective Study
Michael David Jain, Syeda Saba Kareem, Sushmita Khadka, Jose Sandoval‐Sus et al.
Citations
1 citations
Journal
Blood
Topics
Monoclonal and Polyclonal Antibodies Research
Field-Weighted Citation Impact (FWCI)
0.40
article
CD20xCD3 Bispecific Antibodies As Standard of Care (SOC) for Relapse/Refractory (R/R) Large B-Cell Lymphoma (LBCL) - a Multicenter Retrospective Study
Michael David Jain, Syeda Saba Kareem, Sushmita Khadka, Jose Sandoval‐Sus, Ning Dong, Madiha Iqbal, Tiba Al Sagheer, Juan Pablo Alderuccio, Julio C. Chávez, Carlos Silva Rondon, Ariel Perez Perez, Cristian Rodriguez Arocho
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
BloodVol. 144(Supplement 1)
Institutions
University of Miami (US), Moffitt Cancer Center (US), Baptist Health South Florida (US), Memorial Healthcare System (US), Auxilio Mutuo Hospital (PR), Mayo Clinic in Florida (US), Sylvester Comprehensive Cancer Center (US)